We are live on ! Find out more
VCYT icon

Veracyte

278 hedge funds and large institutions have $2.31B invested in Veracyte in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 102 increasing their positions, 103 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.34% more ownership

Funds ownership: 108.68%109.03% (+0.34%)

1% less repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 103

3% less funds holding

Funds holding: 287278 (-9)

8% less capital invested

Capital invested by funds: $2.51B → $2.31B (-$204M)

16% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 43

91% less call options, than puts

Call options by funds: $48K | Put options by funds: $513K

100% less funds holding in top 10

Funds holding in top 10: 30 (-3)

Holders
278
Holders Change
-9
Holders Change %
-3.14%
% of All Funds
3.66%
Holding in Top 10
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
New
36
Increased
102
Reduced
103
Closed
43
Calls
$48K
Puts
$513K
Net Calls
-$465K
Net Calls Change
-$423K
Name Holding Trade Value Shares
Change
Change in
Stake
OAM
26
Oberweis Asset Management
Illinois
$19.6M -$1.24M -42,860 -6%
SCM
27
Soleus Capital Management
Connecticut
$19.3M +$20.7M +715,439 New
EAM
28
Eventide Asset Management
Massachusetts
$18.5M
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$18.3M +$275K +9,509 +1%
GIP
30
Granite Investment Partners
California
$17.2M -$325K -11,208 -2%
DM
31
Deerfield Management
New York
$16.9M +$18.1M +625,000 New
Renaissance Technologies
32
Renaissance Technologies
New York
$16.5M -$6.42M -221,600 -27%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$16.5M +$2.1M +72,441 +14%
Legal & General Group
34
Legal & General Group
United Kingdom
$15.7M +$3.92M +135,440 +30%
SBH
35
Segall Bryant & Hamill
Illinois
$12.9M +$221K +7,640 +2%
Macquarie Group
36
Macquarie Group
Australia
$12.7M +$640K +22,109 +5%
Citadel Advisors
37
Citadel Advisors
Florida
$12.6M +$11.9M +409,252 +721%
SCM
38
Silverarc Capital Management
Massachusetts
$12.1M -$5.37M -185,337 -29%
Loomis, Sayles & Company
39
Loomis, Sayles & Company
Massachusetts
$11.1M -$2.12M -73,250 -15%
SEI Investments
40
SEI Investments
Pennsylvania
$9.73M +$1.94M +67,123 +23%
UBS AM
41
UBS AM
Illinois
$9.3M +$4.29M +148,176 +76%
JP Morgan Chase
42
JP Morgan Chase
New York
$9.11M +$7.04M +243,111 +259%
Arrowstreet Capital
43
Arrowstreet Capital
Massachusetts
$8.8M -$4.79M -165,322 -34%
Invesco
44
Invesco
Georgia
$8.66M +$619K +21,373 +7%
UBS Group
45
UBS Group
Switzerland
$8.39M -$1.22M -42,123 -12%
AAMU
46
AEGON Asset Management (UK)
United Kingdom
$8.2M -$10.1M -348,892 -53%
Barclays
47
Barclays
United Kingdom
$8.1M +$4.67M +161,342 +117%
Jane Street
48
Jane Street
New York
$8.01M +$2.3M +79,355 +37%
Connor, Clark & Lunn Investment Management (CC&L)
49
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$7.55M +$1.3M +44,992 +19%
CC
50
Casdin Capital
New York
$7.47M

VCYT Hedge Fund Activity: Q2 2025 in Review

278 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2025, worth a combined $2.31B — down 8.1% from $2.51B a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of VCYT and 36 opened new positions — a net loss of 7 holders — while 103 trimmed existing stakes and 102 added.

The largest buyer was Artisan Partners, adding an estimated $31.3M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $40.1M sold.

  • 278 institutional investors held Veracyte (VCYT) as of Q2 2025, down from 287 in Q1 2025.
  • Funds reported $2.31B of Veracyte stock for Q2 2025, down 8.1% quarter-over-quarter.
  • 36 funds opened new Veracyte positions in Q2 2025 and 43 closed out, a net change of -7 holders.
  • The largest Veracyte buyer in Q2 2025 was Artisan Partners, an estimated $31.3M added.
  • The largest Veracyte seller in Q2 2025 was Driehaus Capital Management, an estimated $40.1M sold.

Based on aggregated 13F filings for Q2 2025.